原始文献：1.Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy[J]. Eur Heart J, 2018, 39(34): 3165-3241.
2.Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine[J]. Circulation, 2010, 121(13): e266-369.
3.van Hagen IM, Boersma E, Johnson MR, et al. Global cardiac risk assessment in the Registry Of Pregnancy And Cardiac disease: results of a registry from the European Society of Cardiology[J]. Eur J Heart Fail, 2016, 18(5): 523-533.
4.Smith K, Gros B. Pregnancy-related acute aortic dissection in Marfan syndrome: A review of the literature[J]. Congenit Heart Dis, 2017, 12(3): 251-260.
5.Ong KT, Perdu J, De Backer J, et al. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomized, open, blinded-endpoints trial[J]. Lancet, 2010, 376(9751): 1476-1484.
6.Coulon C. Thoracic aortic aneurysms and pregnancy[J]. Presse Med, 2015, 44(11): 1126-1135.